Awarded
Lote 4: Vacunas inactivadas producidas a partir de virus crecidos en cultivos celulares de virus fraccionados o de antígenos de superficie (H y N), o análogas, de 15 microgramos de hemaglutinina de cada cepa incluida en la vacuna. Número de dosis: 30.000
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- SEQIRUS SPAIN SL
- Contract value
- €231,000
- Bids received
- 1
- Published
- 31 Aug 2026
- Awarded
- 4 Aug 2026
- Contract start
- 4 Aug 2026
- Contract end
- 5 Aug 2027estimated
- Region
- Cantabria